RDZNRoadzen Inc.

Nasdaq www.roadzen.io


$ 2.78 $ 0.04 (1.45 %)    

Friday, 05-Jul-2024 15:58:05 EDT
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 2.79
$ 2.70
$ 0.00 x 0
$ 0.00 x 0
$ 2.48 - $ 2.80
$ 1.55 - $ 14.10
986,662
na
122.85M
$ 0.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-01-2024 03-31-2024 10-K
2 02-12-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 08-16-2023 06-30-2023 10-Q
5 05-19-2023 03-31-2023 10-Q
6 04-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stocks-hold-steady-as-powell-reassures-on-disinflation-path-warns-about-debt-risks-tesla-rallies-job-openings-spike-whats-driving-markets-tuesday

U.S. equities were little moved on Tuesday as investors continued to assess the potential for interest rate cuts following the ...

 why-insurance-technology-company-roadzen-shares-are-gaining-today

Roadzen reported robust revenue growth for fiscal year 2024 and inclusion in Russell indexes.

Core News & Articles
Market-Moving News for July 2nd
07/02/2024 12:29:43

RDZN: 81% | Roadzen shares are trading higher following FY24 earnings. RCM: -10% | R1 RCM shares are trading lower after the c...

 maxim-group-initiates-coverage-on-roadzen-with-buy-rating-announces-price-target-of-10

Maxim Group analyst Allen Klee initiates coverage on Roadzen (NASDAQ:RDZN) with a Buy rating and announces Price Target of $10.

 dalmia-transport-selects-roadzens-drivebuddyai-to-enhance-fleet-safety-with-advanced-computer-vision-in-5-year-partnership

Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance...

 marinus-pharmaceuticals-neumora-therapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.